CHPA Hails Multi-State Effort to Prevent the Diversion of OTCs to Manufacture Methamphetamine

Electronic tracking system provides effective, proven solution for law enforcement

Washington, D.C. (November 20, 2009)—The Consumer Healthcare Products Association issued the following statement in support of today’s announcement highlighting the multi-state implementation of the National Precursor Log Exchange system or NPLEx to combat domestic methamphetamine production:

“We commend Governor Beshear, and the Illinois and Louisiana law enforcement officials, for spearheading this multi-state initiative to control the diversion of over-the-counter (OTC) medicines containing pseudoephedrine (PSE) to manufacture methamphetamine. CHPA agrees that implementation of a multi-state electronic tracking system in retail outlets will provide law enforcement with an effective, proven solution to reduce domestic methamphetamine production. This unprecedented effort to collaborate and implement a system aimed at helping law enforcement underscores these states’ commitment to effectively address domestic methamphetamine production.

“CHPA recognizes that home meth labs are dangerous and toxic for communities, as well as a burden for law enforcement, and is pleased to lend its support to aggressive measures to stop domestic meth production. Our member companies share law enforcement’s goal of preventing illegal sales of PSE and are offering to fund the National Precursor Log Exchange system (NPLEx) to states that adopt mandatory electronic PSE sales tracking to tackle critical meth lab problems. We believe that electronic tracking is the only solution that allows for real-time, stop sale of these medicines illegally diverted to manufacture meth while maintaining consumer access to safe and effective cold and allergy medicines.”

Contact: Elizabeth Funderburk, 202.256.5677

CHPA is the 128-year-old-trade association representing U.S. manufacturers and distributors of over-the-counter medicines and nutritional supplements.